The adhesion receptor β3 integrin regulates diverse cellular functions in various tissues. As β3 integrin has been implicated in extracellular matrix (ECM) remodeling, we sought to explore the role of β3 integrin in cardiac fibrosis by using wild type (WT) and β3 integrin null (β3？/？) mice for in vivo pressure overload (PO) and in vitro primary cardiac fibroblast phenotypic studies. Compared to WT mice, β3？/？ mice upon pressure overload hypertrophy for 4 wk by transverse aortic constriction (TAC) showed a substantially reduced accumulation of interstitial fibronectin and collagen. Moreover, pressure overloaded LV from β3？/？ mice exhibited reduced levels of both fibroblast proliferation and fibroblast-specific protein-1 (FSP1) expression in early time points of PO. To test if the observed impairment of ECM accumulation in β3？/？ mice was due to compromised cardiac fibroblast function, we analyzed primary cardiac fibroblasts from WT and β3？/？ mice for adhesion to ECM proteins, cell spreading, proliferation, and migration in response to platelet derived growth factor-BB (PDGF, a growth factor known to promote fibrosis) stimulation. Our results showed that β3？/？ cardiac fibroblasts exhibited a significant reduction in cell-matrix adhesion, cell spreading, proliferation and migration. In addition, the activation of PDGF receptor associated tyrosine kinase and non-receptor tyrosine kinase Pyk2, upon PDGF stimulation were impaired in β3？/？ cells. Adenoviral expression of a dominant negative form of Pyk2 (Y402F) resulted in reduced accumulation of fibronectin. These results indicate that β3 integrin-mediated Pyk2 signaling in cardiac fibroblasts plays a critical role in PO-induced cardiac fibrosis.
References
[1]
Manso AM, Kang SM, Ross RS (2009) Integrins, focal adhesions, and cardiac fibroblasts. Journal of investigative medicine : the official publication of the American Federation for Clinical Research 57: 856–860.
[2]
Shai SY, Harpf AE, Babbitt CJ, Jordan MC, Fishbein MC, et al. (2002) Cardiac myocyte-specific excision of the beta1 integrin gene results in myocardial fibrosis and cardiac failure. Circ Res 90: 458–464.
[3]
Willey CD, Balasubramanian S, Rodriguez Rosas MC, Ross RS, Kuppuswamy D (2003) Focal complex formation in adult cardiomyocytes is accompanied by the activation of beta3 integrin and c-Src. J Mol Cell Cardiol 35: 671–683.
[4]
Ervasti JM (2003) Costameres: the Achilles' heel of Herculean muscle. J Biol Chem 278: 13591–13594.
[5]
Johnston RK, Balasubramanian S, Kasiganesan H, Baicu CF, Zile MR, et al. (2009) Beta3 integrin-mediated ubiquitination activates survival signaling during myocardial hypertrophy. The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 23: 2759–2771.
[6]
Kuppuswamy D (2002) Importance of integrin signaling in myocyte growth and survival. Circ Res 90: 1240–1242.
[7]
Willey CD, Palanisamy AP, Johnston RK, Mani SK, Shiraishi H, et al. (2008) STAT3 activation in pressure-overloaded feline myocardium: role for integrins and the tyrosine kinase BMX. International journal of biological sciences 4: 184–199.
[8]
Balasubramanian S, Kuppuswamy D (2003) RGD-containing peptides activate S6K1 through beta3 integrin in adult cardiac muscle cells. J Biol Chem 278: 42214–42224.
[9]
Zachary I, Gliki G (2001) Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovascular research 49: 568–581.
[10]
Hauselmann SP, Rosc-Schluter BI, Lorenz V, Plaisance I, Brink M, et al. (2011) beta1-Integrin is up-regulated via Rac1-dependent reactive oxygen species as part of the hypertrophic cardiomyocyte response. Free radical biology & medicine 51: 609–618.
[11]
Harston RK, Kuppuswamy D (2011) Integrins are the necessary links to hypertrophic growth in cardiomyocytes. Journal of signal transduction 2011: 521742.
[12]
Bowers SL, Banerjee I, Baudino TA (2010) The extracellular matrix: at the center of it all. J Mol Cell Cardiol 48: 474–482.
[13]
Manso AM, Kang SM, Plotnikov SV, Thievessen I, Oh J, et al. (2009) Cardiac fibroblasts require focal adhesion kinase for normal proliferation and migration. American journal of physiology Heart and circulatory physiology 296: H627–638.
[14]
Suryakumar G, Kasiganesan H, Balasubramanian S, Kuppuswamy D (2010) Lack of beta3 integrin signaling contributes to calpain-mediated myocardial cell loss in pressure-overloaded myocardium. Journal of cardiovascular pharmacology 55: 567–573.
[15]
Anthis NJ, Campbell ID (2011) The tail of integrin activation. Trends Biochem Sci 36: 191–198.
[16]
Hodivala-Dilke KM, McHugh KP, Tsakiris DA, Rayburn H, Crowley D, et al. (1999) Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest 103: 229–238.
[17]
Zile MR, Baicu CF, Stroud RE, Van Laer A, Arroyo J, et al. (2012) Pressure overload-dependent membrane type 1-matrix metalloproteinase induction: relationship to LV remodeling and fibrosis. American journal of physiology Heart and circulatory physiology 302: H1429–1437.
[18]
Harris BS, Zhang Y, Card L, Rivera LB, Brekken RA, et al. (2011) SPARC regulates collagen interaction with cardiac fibroblast cell surfaces. American journal of physiology Heart and circulatory physiology 301: H841–847.
[19]
Bradshaw AD, Baicu CF, Rentz TJ, Van Laer AO, Boggs J, et al. (2009) Pressure overload-induced alterations in fibrillar collagen content and myocardial diastolic function: role of secreted protein acidic and rich in cysteine (SPARC) in post-synthetic procollagen processing. Circulation 119: 269–280.
[20]
Gopal U, Bohonowych JE, Lema-Tome C, Liu A, Garrett-Mayer E, et al. (2011) A novel extracellular Hsp90 mediated co-receptor function for LRP1 regulates EphA2 dependent glioblastoma cell invasion. PloS one 6: e17649.
[21]
Bradshaw AD, Francki A, Motamed K, Howe C, Sage EH (1999) Primary mesenchymal cells isolated from SPARC-null mice exhibit altered morphology and rates of proliferation. Molecular biology of the cell 10: 1569–1579.
[22]
Bates E, Bode C, Costa M, Gibson CM, Granger C, et al. (2008) Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Circulation 117: 886–896.
[23]
Schneider M, Kostin S, Strom CC, Aplin M, Lyngbaek S, et al. (2007) S100A4 is upregulated in injured myocardium and promotes growth and survival of cardiac myocytes. Cardiovascular research 75: 40–50.
[24]
Shindo T, Manabe I, Fukushima Y, Tobe K, Aizawa K, et al. (2002) Kruppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nature medicine 8: 856–863.
[25]
Gough W, Hulkower KI, Lynch R, McGlynn P, Uhlik M, et al. (2011) A quantitative, facile, and high-throughput image-based cell migration method is a robust alternative to the scratch assay. Journal of biomolecular screening 16: 155–163.
[26]
Murasawa S, Matsubara H, Mori Y, Masaki H, Tsutsumi Y, et al. (2000) Angiotensin II initiates tyrosine kinase Pyk2-dependent signalings leading to activation of Rac1-mediated c-Jun NH2-terminal kinase. The Journal of biological chemistry 275: 26856–26863.
[27]
Brown RD, Ambler SK, Mitchell MD, Long CS (2005) The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annual review of pharmacology and toxicology 45: 657–687.
[28]
Weber KT, Anversa P, Armstrong PW, Brilla CG, Burnett JC Jr, et al. (1992) Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol 20: 3–16.
[29]
Ren J, Avery J, Zhao H, Schneider JG, Ross FP, et al. (2007) Beta3 integrin deficiency promotes cardiac hypertrophy and inflammation. J Mol Cell Cardiol 42: 367–377.
[30]
Clemente CF, Tornatore TF, Theizen TH, Deckmann AC, Pereira TC, et al. (2007) Targeting focal adhesion kinase with small interfering RNA prevents and reverses load-induced cardiac hypertrophy in mice. Circ Res 101: 1339–1348.
[31]
Nyberg P, Salo T, Kalluri R (2008) Tumor microenvironment and angiogenesis. Frontiers in bioscience : a journal and virtual library 13: 6537–6553.
[32]
Hsueh WA, Law RE, Do YS (1998) Integrins, adhesion, and cardiac remodeling. Hypertension 31: 176–180.
[33]
Taddei ML, Giannoni E, Fiaschi T, Chiarugi P (2011) Anoikis: an emerging hallmark in health and diseases. The Journal of pathology.
[34]
Arslan F, Smeets MB, Riem Vis PW, Karper JC, Quax PH, et al. (2011) Lack of fibronectin-EDA promotes survival and prevents adverse remodeling and heart function deterioration after myocardial infarction. Circ Res 108: 582–592.
[35]
Hodivala-Dilke KM, McHugh KP, Tsakiris DA, Rayburn H, Crowley D, et al. (1999) Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. The Journal of clinical investigation 103: 229–238.
[36]
Ishigaki T, Imanaka-Yoshida K, Shimojo N, Matsushima S, Taki W, et al. (2011) Tenascin-C enhances crosstalk signaling of integrin alphavbeta3/PDGFR-beta complex by SRC recruitment promoting PDGF-induced proliferation and migration in smooth muscle cells. Journal of cellular physiology 226: 2617–2624.
[37]
Majhen D, Stojanovic N, Speljko T, Brozovic A, De Zan T, et al. (2011) Increased expression of the coxsackie and adenovirus receptor downregulates alphavbeta3 and alphavbeta5 integrin expression and reduces cell adhesion and migration. Life sciences 89: 241–249.
[38]
McHugh KP, Hodivala-Dilke K, Zheng MH, Namba N, Lam J, et al. (2000) Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest 105: 433–440.
[39]
Morgan EA, Schneider JG, Baroni TE, Uluckan O, Heller E, et al. (2010) Dissection of platelet and myeloid cell defects by conditional targeting of the beta3-integrin subunit. The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 24: 1117–1127.
[40]
Stewart JA Jr, Massey EP, Fix C, Zhu J, Goldsmith EC, et al. (2010) Temporal alterations in cardiac fibroblast function following induction of pressure overload. Cell and tissue research 340: 117–126.
[41]
Mulgrew K, Kinneer K, Yao XT, Ward BK, Damschroder MM, et al. (2006) Direct targeting of alphavbeta3 integrin on tumor cells with a monoclonal antibody, Abegrin. Molecular cancer therapeutics 5: 3122–3129.
[42]
Huntley BK, Ichiki T, Sangaralingham SJ, Chen HH, Burnett JC Jr (2010) B-type natriuretic peptide and extracellular matrix protein interactions in human cardiac fibroblasts. Journal of cellular physiology 225: 251–255.
[43]
Danen EH, van Rheenen J, Franken W, Huveneers S, Sonneveld P, et al. (2005) Integrins control motile strategy through a Rho-cofilin pathway. The Journal of cell biology 169: 515–526.
[44]
Montero JC, Seoane S, Ocana A, Pandiella A (2011) Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 17: 5546–5552.
[45]
Borges E, Jan Y, Ruoslahti E (2000) Platelet-derived growth factor receptor beta and vascular endothelial growth factor receptor 2 bind to the beta 3 integrin through its extracellular domain. The Journal of biological chemistry 275: 39867–39873.
[46]
Sanjay A, Houghton A, Neff L, DiDomenico E, Bardelay C, et al. (2001) Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility. J Cell Biol 152: 181–195.
[47]
Destaing O, Sanjay A, Itzstein C, Horne WC, Toomre D, et al. (2008) The Tyrosine Kinase Activity of c-Src Regulates Actin Dynamics and Organization of Podosomes in Osteoclasts. Mol Biol Cell 19: 394–404.
[48]
Dalla Costa AP, Clemente CF, Carvalho HF, Carvalheira JB, Nadruz W Jr, et al. (2010) FAK mediates the activation of cardiac fibroblasts induced by mechanical stress through regulation of the mTOR complex. Cardiovascular research 86: 421–431.
[49]
Lipinski CA, Loftus JC (2010) Targeting Pyk2 for therapeutic intervention. Expert opinion on therapeutic targets 14: 95–108.
[50]
Gil-Henn H, Destaing O, Sims NA, Aoki K, Alles N, et al. (2007) Defective microtubule-dependent podosome organization in osteoclasts leads to increased bone density in Pyk2(？/？) mice. J Cell Biol 178: 1053–1064.
